Name: Latest research reports of Biocon Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: ICICI Securities Limited

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

339.4000 0.80 (0.24%)

NSE May 16, 2025 15:31 PM

25.91% Gain from 52W Low

Volume: 2.0M

Biocon Ltd.

29 Jan 2018

339.40

0.24%

Biocon

Buy: Biocon Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Biocon reported flat YoY revenues at | 1058 crore (I-direct estimate: | 1073 crore). Biopharmaceutical segment declined 9% YoY to 369...

Biocon Ltd. has an average target of 389.25 from 4 brokers.